Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339493 · ClinicalTrials.gov registry record · NA
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 458
- Enrollment target
NCT02339493 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 458 participants.
The verdict
NCT02339493, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 458 participants
- Enrollment target
Study Summary
Atrial fibrillation (AF) is the most preventable cause of stroke. CHADS and CHA2DS2VASc scores predict the likelihood of stroke in patients with nonvalvular AF. Atrial flutter confers a similar risk of stroke as atrial fibrillation. Anticoagulant therapy with warfarin, dabigatran, rivaroxaban, apixaban, and edoxaban is effective for prevention of thromboembolic stroke in most patients with AF. However, despite widely available risk stratification tools, five options for anticoagulation, and evidence-based practice guidelines, thromboprophylaxis for stroke prevention in AF is under-prescribed in the U.S., Europe, and worldwide. The investigators have previously demonstrated the efficacy of an alert-based computerized decision support (CDS) strategy for prevention of symptomatic venous thromboembolism (VTE) in at-risk hospitalized patients not receiving any thromboprophylaxis. The investigators' goal is to create and evaluate an alert-based CDS strategy for stroke prevention in patients with nonvalvular AF or atrial flutter in a randomized controlled trial.
Interventions
- OTHER Computer Electronic Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02339493
The ClinicalTrials.gov registry entry for NCT02339493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 458 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computer Electronic Alert is the first listed.
NCT02339493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02339493 about?
NCT02339493 is a clinical study titled "Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter". Atrial fibrillation (AF) is the most preventable cause of stroke. CHADS and CHA2DS2VASc scores predict the likelihood of stroke in patients with nonvalvular AF. Atrial flutter confers a similar risk of stroke as atrial fibrillation. Anticoagulant therapy with warfarin, dabigatran, rivaroxaban, apixa...
What is the current status of trial NCT02339493?
This trial is currently completed. It is a NA study. The enrollment target is 458 participants. The study started on 2016-05. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02339493?
The interventions under investigation include: Computer Electronic Alert (OTHER).
Who is sponsoring clinical trial NCT02339493?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.